Boston Scientific Corporation (BSX)
USD 88.03
(-2.65%)
USD 88.03
(-2.65%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Revenue | 14.24 Billion | 12.68 Billion | 11.88 Billion | 9.91 Billion | 10.73 Billion | 9.82 Billion |
| Cost of Revenue | 4.34 Billion | 4 Billion | 3.76 Billion | 3.51 Billion | 3.18 Billion | 2.88 Billion |
| Gross Profit | 9.89 Billion | 8.67 Billion | 8.12 Billion | 6.4 Billion | 7.55 Billion | 6.94 Billion |
| Operating Expenses | 7.47 Billion | 6.64 Billion | 6.3 Billion | 5.71 Billion | 5.81 Billion | 5.28 Billion |
| Selling, General and Administrative Expenses | 5.19 Billion | 4.52 Billion | 4.35 Billion | 3.78 Billion | 3.94 Billion | 3.56 Billion |
| Research and Development Expenses | 1.41 Billion | 1.32 Billion | 1.2 Billion | 1.14 Billion | 1.17 Billion | 1.11 Billion |
| Other Expenses | 948 Million | 803 Million | 741 Million | 789 Million | 699 Million | 156 Million |
| Cost and Expenses | 11.82 Billion | 10.64 Billion | 10.06 Billion | 9.22 Billion | 8.99 Billion | 8.16 Billion |
| Operating Income | 2.34 Billion | 1.64 Billion | 2.04 Billion | 1.04 Billion | 1.51 Billion | 1.5 Billion |
| Interest Expense | 265 Million | 470 Million | 341 Million | 361 Million | 473 Million | 241 Million |
| Income Tax Expense | 393 Million | 443 Million | 36 Million | 2 Million | -4.01 Billion | -249 Million |
| Earnings before Tax | 1.98 Billion | 1.14 Billion | 1.07 Billion | -138 Million | 687 Million | 1.42 Billion |
| Net Income | 1.59 Billion | 698 Million | 1.04 Billion | -140 Million | 4.7 Billion | 1.67 Billion |
| Earnings Per Share Basic | 1.08 | 0.45 | 0.69 | -0.10 | 3.38 | 1.21 |
| Earnings Per Share Diluted | 1.07 | 0.45 | 0.69 | -0.10 | 3.33 | 1.19 |
| Weighted Average Shares Outstanding | 1.45 Billion | 1.43 Billion | 1.42 Billion | 1.41 Billion | 1.39 Billion | 1.38 Billion |
| Weighted Average Shares Outstanding (Diluted) | 1.46 Billion | 1.43 Billion | 1.43 Billion | 1.41 Billion | 1.41 Billion | 1.4 Billion |
| Gross Margin | 0.69 | 0.68 | 0.68 | 0.65 | 0.70 | 0.71 |
| EBIT Margin | 0.24 | 0.22 | 0.23 | 0.18 | 0.19 | 0.25 |
| Profit Margin | 0.11 | 0.06 | 0.09 | -0.01 | 0.44 | 0.17 |
| EBITDA | 3.45 Billion | 2.74 Billion | 2.51 Billion | 1.51 Billion | 2.21 Billion | 2.58 Billion |
| Earnings Before Tax Margin | 0.16 | 0.13 | 0.17 | 0.11 | 0.14 | 0.15 |
| Breakdown | 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 |
|---|---|---|---|---|---|---|
| Revenue | 4.2 Billion | 4.12 Billion | 3.85 Billion | 14.24 Billion | 3.72 Billion | 3.52 Billion |
| Cost of Revenue | 1.31 Billion | 1.53 Billion | 1.2 Billion | 4.34 Billion | 1.14 Billion | 1.11 Billion |
| Gross Profit | 2.89 Billion | 2.58 Billion | 2.64 Billion | 9.89 Billion | 2.57 Billion | 2.41 Billion |
| Operating Expenses | 2.17 Billion | 1.83 Billion | 1.95 Billion | 7.47 Billion | 1.96 Billion | 1.8 Billion |
| Selling, General and Administrative Expenses | 1.56 Billion | 1.44 Billion | 1.36 Billion | - | 1.37 Billion | 1.24 Billion |
| Research and Development Expenses | 407 Million | 383 Million | 366 Million | - | 363 Million | 356 Million |
| Other Expenses | -210 Million | -9 Million | -224 Million | -14 Million | 64 Million | -18 Million |
| Cost and Expenses | 3.49 Billion | 3.37 Billion | 3.16 Billion | 11.82 Billion | 3.1 Billion | 2.91 Billion |
| Operating Income | 718 Million | 747 Million | 693 Million | 2.34 Billion | 584 Million | 693 Million |
| Interest Expense | 79 Million | 77 Million | 69 Million | 265 Million | 65 Million | 66 Million |
| Income Tax Expense | 200 Million | 98 Million | 115 Million | 393 Million | 1 Million | 105 Million |
| Earnings before Tax | 669 Million | 420 Million | 608 Million | 1.98 Billion | 505 Million | 610 Million |
| Net Income | 468 Million | 324 Million | 492 Million | 1.59 Billion | 505 Million | 504 Million |
| Earnings Per Share Basic | 0.32 | 0.22 | 0.34 | - | 0.34 | 0.34 |
| Earnings Per Share Diluted | 0.32 | 0.22 | 0.33 | - | 0.34 | 0.34 |
| Weighted Average Shares Outstanding | 1.47 Billion | 1.47 Billion | 1.46 Billion | 1.45 Billion | 1.46 Billion | 1.46 Billion |
| Weighted Average Shares Outstanding (Diluted) | 1.48 Billion | 1.48 Billion | 1.48 Billion | 1.46 Billion | 1.47 Billion | 1.47 Billion |
| Gross Margin | 0.69 | 0.63 | 0.69 | 0.69 | 0.69 | 0.68 |
| EBIT Margin | 0.18 | 0.26 | 0.26 | - | 0.27 | 0.23 |
| Profit Margin | 0.11 | 0.08 | 0.13 | 0.11 | 0.14 | 0.14 |
| EBITDA | 747 Million | 1.05 Billion | 1 Billion | - | 1.01 Billion | 801 Million |
| Earnings Before Tax Margin | 0.17 | 0.18 | 0.18 | 0.16 | 0.16 | 0.20 |
ENZY
ACON
KEIL
PRIMEPRO
SUKHJITS
MCFT